Smartleaf Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Smartleaf Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$455K	Hold	28,454	–	–	0.01%	577
2026 Q1	$520K	Buy	28,454 +3,682	+15%	+$64.6K	0.02%	525
2025 Q4	$387K	Buy	24,772 +4,877	+25%	+$69.7K	0.01%	583
2025 Q3	$291K	Buy	19,895 +9,066	+84%	+$135K	0.02%	610
2025 Q2	$164K	Buy	10,829 +450	+4%	+$6.65K	0.01%	652
2025 Q1	$156K	Buy	10,379 +359	+4%	+$5.03K	0.02%	652
2024 Q4	$132K	Buy	10,020 +7,972	+389%	+$110K	0.01%	717
2024 Q3	$29.8K	Buy	2,048 +996	+95%	+$14.1K	﹤0.01%	1121
2024 Q2	$13.6K	Buy	1,052 +845	+408%	+$11.2K	﹤0.01%	1244
2024 Q1	$2.94K	Sell	207 -6,759	-97%	-$98.3K	﹤0.01%	1385
2023 Q4	$99K	Buy	+6,966	New	+$98.8K	0.03%	427

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Smartleaf Asset Management's TAK Position: Q2 2026 in Review

Smartleaf Asset Management held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 28,454 shares worth $455K. The position accounts for 0.01% of the portfolio, ranked #577.

Smartleaf Asset Management first reported a position in TAK in Q4 2023 and has held it in 11 quarters since. The position peaked at $520K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Smartleaf Asset Management held 28,454 shares of Takeda Pharmaceutical worth $455K as of Q2 2026.
Smartleaf Asset Management left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #577 holding.
Smartleaf Asset Management first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
Smartleaf Asset Management's Takeda Pharmaceutical position peaked at $520K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.